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Interdomain interactionThe vertebrate egg coat, including mammalian zona pellucida, is an oocyte-speciﬁc extracellular
matrix comprising two to six zona pellucida (ZP) glycoproteins. The egg coat plays important roles
in fertilization, especially in species-speciﬁc interactions with sperm to induce the sperm acrosome
reaction and to form the block to polyspermy. It is suggested that the physiological functions of the
egg coat are mediated and/or regulated coordinately by peptide and carbohydrate moieties of the ZP
glycoproteins that are spatially arranged in the egg coat, whereas a comprehensive understanding of
the architecture of vertebrate egg-coat matrix remains elusive. Here, we deduced the orientations
and/or distributions of chicken ZP glycoproteins, ZP1, ZP3 and ZPD, in the egg-coat matrix by con-
focal immunoﬂuorescent microscopy, and in the ZP1–ZP3 complexes generated in vitro by
co-immunoprecipitation assays. We further conﬁrmed interdomain interactions of the ZP glycopro-
teins by far-Western blot analyses of the egg-coat proteins and pull-down assays of ZP1 in the
serum, using recombinant domains of ZP glycoproteins as probes. Our results suggest that the
ZP1 and ZP3 bind through their ZP-C domains to form the ZP1–ZP3 complexes and ﬁbrils, which
are assembled into bundles through interactions between the repeat domains of ZP1 to form the
ZP1–ZP3 matrix, and that the ZPD molecules self-associate and bind to the ZP1–ZP3 matrix through
its ZP-N and ZP-C domains to form the egg-coat matrix. Based on these results, we propose a
tentative model for the architecture of the chicken egg-coat matrix that might be applicable to other
vertebrate ones.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The vertebrate egg coat (zona pellucida in mammals) surround-
ing the ovulated oocyte is a unique ﬁbrous extracellular matrix
[1,2]. The egg coat is involved in the egg–sperm interactions
including taxon-speciﬁc gamete recognition, induction of sperm
acrosome reaction, sperm penetration through the egg coat, and
block to polyspermy [1,2]. These gamete interactions are at least
partly due to the sperm–egg coat (or sperm–zona) interactions that
is mediated by the egg-coat components, i.e. the zona pellucida(ZP) glycoproteins, and the sperm proteins such as zonadhesin
[3,4], SED1 [5], ADAM3 [6,7], CRISP1 [8], acrosin/proacrosin
[9,10], or the egg cortical-granule protease, ovastacin [11],
although physiological contributions of the sperm–zona interac-
tions to normal fertilization remain controversial [12,13]. The ZP
glycoproteins are characterized by conserved 260-aa-long ZP
domain [14] containing two unique immunoglobulin-like folds,
named ZP-N and ZP-C domains, respectively [15,16], and classiﬁed
into totally 6 subfamilies designated ZP1, ZP2/ZPA, ZP3/ZPC,
ZP4/ZPB, ZPD and ZPAX, respectively, based on phylogenetic anal-
yses [17,18]. These egg-coat components can also be distinguished
by their domain structures in the N-terminal ﬂanking region of the
ZP-N domain, and the structural diversities of the ZP-C domain. For
example, on the N terminus of the ZP-N domain of both ZP1 and
ZP4 homologues, there is an additional ZP-N domain (the
N-terminal domain) followed by a trefoil domain, although the
N-terminal and trefoil domains of ZP1 but not of ZP4 possess a free
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respectively [20–22]. Furthermore, there are three additional
ZP-N repeats on the N terminus of the ZP-N domain of ZP2 homo-
logue [19], and a calcium-binding EGF-like domain on that of avian
ZPD homologue [23–25]. In addition, the ZP3 homologue possesses
the type I ZP-C domain (including the ZP-C subdomain) containing
8 Cys residues [16], and the other homologues possess the type II
one containing 6 Cys residues [2,26], except that amphibian ZPD
homologue possess an unusual type-II-like ZP-C domain with 4
Cys residues [23–25]. Interestingly, it is suggested that some of
genes encoding ZP glycoproteins have independently been lost or
become pseudogenes during evolution [18], and consequently,
the mature egg coat is constituted of ZP3 and ZP4 in teleost ﬁsh
[27–29], ZP2, ZP3, ZP4, ZPD and ZPAX in amphibians (Xenopus)
[23,30], ZP1, ZP3, ZPD and under detectable levels or faint amounts
of ZP2, ZP4 and ZPAX in birds (chicken and quail) [24,25,31]. It is
noteworthy that the mammalian egg coat is composed of ZP1,
ZP2, ZP3 and ZP4 in some species including hamster, rat and
human [21,22,32], ZP2, ZP3 and ZP4 in other ones including pig,
cow and dog [33–35], and ZP1, ZP2 and ZP3 only in mouse
[18,32,36].
To date, many studies suggest that sugar chains on the ZP gly-
coproteins play crucial roles in the sperm–zona interactions in
cooperation with the polypeptide backbone [16,37–39]. In most
cases, it has been shown that ZP glycoproteins individually have
abilities to bind to the intact or acrosome-reacted sperm (e.g.,
ZP2 [40,41] and ZP3 [16,42,43] of mouse and human, and ZP3
and ZPD of chicken [16,24]) and/or to induce sperm acrosome reac-
tion (e.g., ZP3 of mouse [44,45] and ZPD of chicken [24]). While in
other cases, for example in cow, ZP3/ZP4 heterodimer but not any
individual ZP glycoproteins bind to sperm [34], and in chicken, the
dimeric form of ZP1 has much higher activity to induce the acro-
some reaction than the monomeric form [24]. These ﬁndings imply
that the interactions between sperm molecule(s) and ZP glycopro-
teins are enhanced or regulated by the speciﬁc orientations of
them including the glycan chains and/or polypeptide backbones
in the egg-coat matrix. Therefore, it is necessary to elucidate the
molecular arrangements of ZP glycoproteins in the egg coat for
understanding how the physiology of the matrix associates with
the functional properties of ZP glycoproteins.
Although molecular mechanisms underlying the egg-coat for-
mation or the intermolecular interactions among ZP glycoproteins
are still poorly understood, some evidence suggest that the ZP
domain is involved in the polymerization of ZP glycoproteins
through their internal hydrophobic patch (IHP) in the N terminus
of ZP-C domain and the E0–F–G region of ZP-N domain [15,16]. It
is also suggested that ZP1 forms disulﬁde-linked homodimers
probably through the above-mentioned free Cys residue of the
N-terminal domains [19,44,46], and at least in chicken, the ZP1
homodimer is formed during the interaction with ZP3 [47,48].
Moreover, two models of the egg-coat architecture are proposed
based on the results from biochemical, electron/light microscopic
and/or gene knockout analyses. That is, the polymers composed
of ZP2–ZP3 heterodimer are cross-linked by the ZP1 homodimers
in mouse [2,49], and the ZPD-complexes are loosely attached to
the insoluble ZP1–ZP3 matrix in chicken [24]. Recently, a series
of the ﬁrst crystal structures have been determined for the ZP-N
domain of mouse ZP3 [50], full-length chicken ZP3 containing both
ZP-N and the type I ZP-C domains [16], and the type II ZP-C
domains of mouse and rat homologues of a non-egg-coat
ZP-domain protein, transforming growth factor (TGF)-b receptor
type 3 (TGFR-3) [51,52]. These structures provide invaluable infor-
mation about the conﬁguration of each domain in the
ZP-glycoprotein molecules and enable us to examine interdomain
interactions being responsible for the egg-coat formation more
directly.In our previous studies, in vitro assays demonstrated that sol-
uble forms of ZP1 in the chicken (i.e. laying hen) serum (serum
ZP1) and ZP3 isolated from the egg coat (egg-coat ZP3) interact
to form insoluble ZP1–ZP3 complexes or the egg-coat matrix-like
ﬁlaments [24,47,48]. In these studies, the ZP1–ZP3 complex was
not immunoprecipitated by an antibody against the C-terminal
region of ZP1 but the one against the other region, suggesting that
ZP domain of ZP1 is involved in the ZP1–ZP3 interactions.
Furthermore, there were no signiﬁcant differences in the binding
abilities of ZP1 to variously glycosylated isoforms of ZP3 [53],
implying that the polypeptide backbone but not the sugar chains
of ZP3 is mainly involved in the formation of the ZP1–ZP3 complex.
Considering that either ZP domain of chicken ZP1 or ZP3 has only
one N-linked glycosylation site [20,54] and that chicken ZP3 has
a single O-glycan [16] in the linker region between ZP-N and
ZP-C domains, it is expected that the polypeptide backbone of ZP
domain in ZP1 and ZP3 plays a major role in the assembly of these
molecules into the egg-coat matrix. In the present study, we pro-
duced recombinant domains of chicken ZP glycoproteins in
Escherichia coli and developed polyclonal antisera against them.
Immunoﬂuorescent staining of the egg coat and
co-immunoprecipitation assays of the serum ZP1 and the
egg-coat ZP3, with the domain-speciﬁc antisera, suggest that speci-
ﬁc domains of ZP1 and ZP3 might be deeply embedded in the
matrix and located at the ZP1–ZP3 interaction interfaces. The dis-
tribution of ZPD in the matrix was also determined by the
immunoﬂuorescent microscopy. Furthermore, we conﬁrmed the
domains of ZP glycoproteins involved in the egg-coat formation
by far-Western blotting of the egg-coat proteins and pull-down
assays of the serum ZP1 with the recombinant domains of ZP gly-
coproteins. Finally, we proposed a tentative model for the architec-
ture of the chicken egg-coat matrix that might be true of other
vertebrate ones. Investigations of the molecular structure and the
underlying formation mechanisms of the egg-coat matrices will
provide important insights into the relationship between the phys-
iological functions and supramolecular structures of them, or the
cooperative activities of the ZP glycoproteins in the sperm–zona
interactions. These insights could be applicable to the reproductive
medicine with novel contraceptives based on the inhibition of the
sperm–zona interactions as well as with therapies for
zona-pellucida related infertilities.
2. Results
2.1. Distinctive staining patterns of egg-coat matrix being observed
with antisera against individual domains of ZP glycoproteins
To analyze detailed distributions and molecular orientations of
ZP1, ZP3 and ZPD in the egg coat, immunoﬂuorescent staining of
them with a series of antisera against the distinct domains of ZP
glycoproteins (see Section 4) and confocal laser-scanning micro-
scopy were performed (Fig. 2A and B). The ﬁlamentous structures
with a diameter of approximately 0.8–1.4 lm were observed in
the differential-interference-contrast (DIC) images of egg coat
(panels 3 and 4 of A). Immunoﬂuorescent staining conﬁrmed that
the near surface of the ﬁlaments was signiﬁcantly labeled with
the antiserum against repeat domain of ZP1 (anti-ZP1_repeat;
panel 2 of A). Interestingly, the anti-ZP1_ZP-N and anti-ZP3_ZP-N
antisera showed punctuate staining patterns along the surface of
the egg-coat ﬁlaments (panels 3 and 6 of B, respectively), and no
staining were detected with the anti-ZP1_ZP-C and anti-ZP3_ZP-C
antisera (panels 4 and 7 of B, respectively), whereas the near sur-
face of the ﬁlaments were labeled with the anti-ZP1_N-terminal,
anti-ZP1_trefoil, and anti-ZP3_N-terminal antisera as well as with
the anti-ZP1_repeat antiserum (panels 1, 2 and 5 of B, respec-
tively). In addition, the interstices of the egg-coat ﬁlaments were
Fig. 1. Schematic representation of the domains of chicken ZP glycoproteins being expressed as fusion proteins. Structural and/or functional domains of ZP glycoproteins
constituting mature chicken egg coat, i.e., ZP1, ZP3 (GenBank: BAA13760) and ZPD (GenBank: BAD13713), were expressed as N-terminal Trx-, His6-, S-tagged fusion proteins
in Escherichia coli as described in Section 4. ZP1 in this study contains an additional 24-aa-long repeat unit in the repeat domain as compared to the currently available
sequence (GenBank: CAC16087). Positions of the domains fused to the tags are shown in the schematic diagrams of chicken ZP glycoproteins. Signal peptides and the C-
terminal peptides containing furin cleavage sites followed by the external hydrophobic patch (EHP) are indicated as ﬁlled and striped rectangles, respectively.
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extent (panels 8–10 of B, respectively). The anti-tag antiserum (see
Section 4) was used as a negative control (panel 1 of A).
2.2. Speciﬁc interactions of recombinant domains of ZP1 with egg-coat
proteins detected by far-Western blot analyses
To identify domains of ZP1 involved in the ZP1–ZP1 and ZP1–
ZP3 interactions in the egg-coat matrix, far-Western blot analyses
using a series of recombinant domains of ZP1 (see Section 4) as
probes were performed (Fig. 3A). Chicken egg-coat proteins were
separated by SDS–PAGE under non-reducing conditions and elec-
troblotted onto nitrocellulose membranes (lanes 1–6) or visualized
by CBB staining (lane 7). Then the membranes were incubated with
the control protein (lane 1; see Section 4) and the recombinant
domains of ZP1 (rZP1_N-terminal, repeat, trefoil, ZP-N and ZP-C)
containing the Trx tag (lanes 2–6, respectively; see Section 4),
respectively, and subsequently with rabbit anti-Trx antibody. The
bands corresponding to monomeric (mo-) and dimeric (di-) forms
of ZP1 and the previously-reported anti-ZP1 positive proteins
[47,53] (asterisks) on the membrane incubated with the
rZP1_repeat (lane 3), and the bands corresponding to ZP3 on the
membrane incubated with the rZP1_ZP-C (lane 6), were detected
at signiﬁcantly higher levels than the other bands. Furthermore,
the bands corresponding to ZP3 and ZPD on the membrane incu-
bated with the rZP1_repeat (lane 3), and the one corresponding
to the anti-ZP1 positive proteins [47,53] (asterisks) on the mem-
brane incubated with the rZP1_ZP-C (lane 6) were also detected,
although at weaker levels. On the other hand, all the bands on
the membranes incubated with the rZP1_N-terminal, trefoil and
ZP-N (lanes 2, 4 and 5, respectively) were detected at levels similar
to control (lane 1).
In addition, we examined whether the interaction of the
rZP1_ZP-C with ZP3 is inhibited by the anti-ZP3_ZP-N and/or
ZP-C antisera (Fig. 3B). Far-Western blotting was performed as
described above except that the nitrocellulose membranes were
preincubated with the mouse anti-tag (lane 1), anti-ZP3_ZP-N
(lane 2) and anti-ZP3_ZP-C (lane 3) antisera, respectively, followed
by incubation with the rZP1_ZP-C as a probe. Unexpectedly, eitherbands corresponding to ZP3 on the membranes preincubated with
the anti-ZP3_ZP-N (lane 2) or anti-ZP3_ZP-C (lane 3) antiserum
was detected similarly to that preincubated with the anti-tag (lane
1).
2.3. Varied efﬁciency of co-immunoprecipitation of ZP1 in the chicken
serum and ZP3 isolated from the egg coat with the antisera against
individual domains of ZP glycoproteins
To predict dispositions of the individual domains of ZP1 and ZP3
in the ZP1–ZP3 complexes, co-immunoprecipitation assays of the
serum ZP1 and the ZP3 isolated from the egg coat (egg-coat ZP3)
with the antisera raised against the domains of ZP1 and ZP3 were
performed (Fig. 4A and B). The chicken serum containing ZP1 was
mixed with the ZP3 solution prepared as described in Section 4 and
incubated to form the ZP1–ZP3 complexes. Antibodies in the antis-
era against ZP1 (anti-ZP1_N-terminal, repeat, trefoil, ZP-N and ZP-C
in A) and ZP3 (anti-ZP3_N-terminal, ZP-N and ZP-C in B) were
immobilized on the protein G beads and then incubated with the
buffer in the presence (+; odd-numbered lanes, except for lane
11, of A and B) or absence (; even-numbered lanes of A and B)
of the serum-ZP3 mixture. The immunoprecipitates on the beads
were subjected to SDS–PAGE under reducing conditions, together
with the chicken serum and the ZP3 solution (upper and lower
panels in lane 11 of A, respectively), followed by immunoblotting
with the anti-ZP1_repeat (anti-ZP1) and anti-ZP3_ZP-C (anti-ZP3)
antisera (upper and lower panels, respectively). Immunoglobulin
heavy and light chains (single and double asterisks, respectively)
were detected by the secondary antibody at similar levels either
in the anti-ZP1 or anti-ZP3 immunoprecipitates (A or B, respec-
tively). Antibodies in the anti-ZP1_N-terminal, repeat and ZP-C
antisera (lanes 1, 3, and 9 of A, respectively) but not ones in the
anti-ZP1_trefoil and ZP-N antisera (lanes 5 and 7 of A, respectively)
efﬁciently co-immunoprecipitated the egg-coat ZP3 (blank arrow-
heads) with the serum ZP1 (ﬁlled arrowheads), while ones in all
the anti-ZP1 antisera immunoprecipitated ZP1 at similarly high
efﬁciencies, from the serum–ZP3 mixture. On the other hand, anti-
bodies in the anti-ZP3_N-terminal and ZP-N antisera (lanes 1 and 3
of B, respectively) but not ones in the anti-ZP3_ZP-C antisera (lane
BA
Fig. 2. Immunoﬂuorescent microscopy of chicken egg-coat matrix. Small pieces of the egg coat were stained with the mouse anti-tag (panels 1 and 3 of A) and anti-
ZP1_repeat antisera (panels 2 and 4 of A), anti-ZP1_N-terminal, trefoil, ZP-N and ZP-C antisera (panels 1–4 of B, respectively), anti-ZP3_N-terminal, ZP-N and ZP-C antisera
(panels 5–7 of B, respectively) and anti-ZPD_EGF, ZP-N and ZP-C antisera (panels 8–10 of B, respectively) being produced as described in Section 4 followed by Alexa Fluor
488 goat anti-mouse IgG, and then observed under a confocal laser-scanning microscope equipped with a 488-nm excitation laser. Light images of differential-interference-
contrast (DIC) microscopy are shown (panels 3 and 4 of A). Bar = 10 lm.
H. Okumura et al. / FEBS Open Bio 5 (2015) 454–465 4575 of B) efﬁciently co-immunoprecipitated the egg-coat ZP3 (blank
arrowheads) and the serum ZP1 (ﬁlled arrowheads) from the
serum–ZP3 mixture.
2.4. Interactions of recombinant ZP-N and ZP-C domains of ZP3 with
ZP1 in the chicken serum being compared by pull-down assays
To identify the domains of chicken ZP3 involved in the forma-
tion of the ZP1–ZP3 complexes, pull-down assays of ZP1 in the
chicken serum were performed using the rZP3_ZP-N and ZP-C as
probes (Fig. 5A and B, respectively). The beads coated with the
rZP3s (lanes 2, 4 and 6) and with the control protein (lanes 3 and
5) were incubated in the presence (lanes 2–5) or absence
(serum–; lanes 6) of the chicken serum containing ZP1. Proteinsbeing bound to the beads were released using 4.0% Triton X-100
(TX-100; lanes 2 and 3) and subsequently 2.0% SDS (SDS; lanes
4–6), and subjected to SDS–PAGE under non-reducing conditions,
together with the chicken serum (lanes 1), followed by
immunoblotting with the anti-ZP1_repeat antiserum (anti-ZP1).
ZP1 (arrowheads) was detected in the 2.0% SDS eluates from the
beads coated with the rZP3_ZP-C (lane 4 of B) at signiﬁcantly
higher levels than that with the rZP3_ZP-N (lane 4 of A). The
anti-ZP1 positive proteins in the serum (single asterisks), and the
ones in the recombinant protein solutions (double asterisks) were
also detected in the 2.0% SDS eluates. Almost no proteins were
detected by the anti-ZP1 in all the 4.0% Triton X-100 eluates (lanes
2 and 3). Since the antisera were raised against the recombinant ZP
glycoproteins containing peptides derived from the tag sequence
A B
Fig. 3. Far-Western blot analyses of the egg-coat proteins with the recombinant domains of ZP1. The egg-coat proteins were separated by SDS–PAGE under non-reducing
conditions followed by electroblotting onto nitrocellulose membranes. (A) The blocked membranes were incubated with the control protein (lane 1), recombinant N-terminal
(N-term), repeat, trefoil, ZP-N and ZP-C domains of ZP1 (rZP1s) (lanes 2–6, respectively; see Fig. 1) as Trx-tagged probes followed by immunostaining with rabbit anti-Trx
antibody. The proteins in the SDS–PAGE gel were also stained with CBB (lane 7). (B) The blocked membranes were preincubated with the mouse anti-tag (lane 1), anti-
ZP3_ZP-N and ZP-C antisera (lanes 2 and 3, respectively) being produced as described in Section 4 prior to the incubation with the recombinant ZP-C domain of ZP1 (rZP1_ZP-
C), and immunostained with rabbit anti-Trx antibody. Migration positions of dimeric (di-) and monomeric (mo-) ZP1, ZPD and ZP3 (arrowheads), and the previously-reported
anti-ZP1 positive proteins (asterisks) are shown on the right. Molecular weights (kDa) are indicated on the left.
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control protein (triple asterisks).
2.5. Speciﬁc interactions of recombinant domains of ZPD with egg-coat
proteins detected by far-Western blot analyses
To identify domains of ZPD involved in the binding to ZPD and
the other ZP glycoproteins, far-Western blot analyses using a series
of recombinant domains of ZPD as probes were performed
(Fig. 6A). Chicken egg-coat proteins (odd-numbered lanes) and
ZPD in the crude ZPD solution (even-numbered lanes) prepared
as described in Section 4 were separated by SDS–PAGE under
non-reducing conditions and electroblotted onto nitrocellulose
membranes (lanes 1–8) or visualized by CBB staining (lanes 9
and 10). Then the membranes were incubated with the control
protein (lanes 1 and 2) and the recombinant domains of ZPD
(rZPD_EGF; lanes 3 and 4, ZP-N; lanes 5 and 6, and ZP-C; lanes 7
and 8) containing the Trx tag (see Section 4), respectively, and sub-
sequently with rabbit anti-Trx antibody. The bands corresponding
to monomeric (mo-) and dimeric (di-) forms of ZP1 on the
membrane incubated with the rZPD_ZP-N and ZP-C (lanes 5 and
7, respectively), the band corresponding to one of the
previously-reported anti-ZP1 positive proteins [47,53] (asterisk)
on the membrane incubated with the rZPD_ZP-N (lane 5), and
the band corresponding to ZPD on the membrane incubated with
the rZPD_ZP-C (lane 8), were detected at signiﬁcantly higher levels
than the other bands. Furthermore, the bands corresponding to
ZPD and ZP3 were detected on the membrane incubated with the
rZPD_ZP-N (lane 6) and the rZPD_ZP-C (lane 7), respectively,
although at weaker levels. On the other hand, all the bands on
the membranes incubated with the rZPD_EGF (lanes 3 and 4) were
detected at levels similar to control (lanes 1 and 2).
In addition, to predict the binding interface between ZPD mole-
cules involved in the formation of the possible ZPD aggregates, we
examined whether the interaction of the rZPD_ZP-C with ZPD is
inhibited by the anti-ZPD_ZP-N and/or ZP-C antisera (Fig. 6B).
Far-Western blotting were performed as described above exceptthat only the crude ZPD solution were subjected to SDS–PAGE,
and that the nitrocellulose membranes were preincubated with
the mouse anti-tag (lane 1), anti-ZPD_ZP-N (lane 2) and
anti-ZPD_ZP-C (lane 3) antisera, respectively, followed by incuba-
tion with the rZPD_ZP-C as a probe. The bands corresponding to
ZPD were detected on the membrane preincubated with the
anti-tag and anti-ZPD_ZP-N (lanes 1 and 2, respectively), but not
on the membrane preincubated with the anti-ZPD_ZP-C (lane 3).
3. Discussion
Structural studies of the egg-coat matrix could provide new
knowledge applicable for designing novel therapies for the infertil-
ity associated with abnormal morphology of the egg coat and
mutations in their unique components, ZP glycoproteins [55–57].
However, despite extensive investigations to elucidate the molec-
ular mechanisms of egg-coat formation and the egg–sperm inter-
actions, a comprehensive understanding of the architecture of
vertebrate egg coat remains elusive [58]. In this study, we further
mapped the domains of ZP glycoproteins involved in the egg-coat
matrix formation using immunohistochemical and biochemical
approaches.
To begin to study the interdomain interactions of ZP glycopro-
teins, we produced the N-terminally Trx-, His6- and S-tagged
recombinant domains of chicken ZP1, ZP3 and ZPD (see Fig. 1),
which are used to generate mouse polyclonal antisera speciﬁc for
the individual domains of ZP glycoproteins (see Supplement
Fig. S1), and as probes in far-Western blot analyses and
pull-down assays. We predicted that the recombinant domains of
ZP glycoproteins being expressed in E. coli could be correctly folded
for the following reasons. (1) Crystal structure of the ZP-N domain
of mouse ZP3 being expressed as a MBP-fusion protein in E. coli
Origami B(DE3) (Novagen) [50] shared structural homology with
that of full-length chicken ZP3 being expressed in CHO cells [16].
(2) The N-terminal domain of ZP1 is an additional copy of the
ZP-N domain [19]. (3) Crystal structures of the type II ZP-C domain
of mouse and rat TGFR-3 being expressed in eukaryotic cells
AB
Fig. 4. Co-immunoprecipitation assays of ZP1 in the chicken serum and ZP3 isolated from the egg coat. The chicken serum containing ZP1 and the ZP3 solution prepared as
described in Section 4 were mixed and incubated to form the ZP1–ZP3 complexes. Protein G magnetic beads coated with the antibodies in the anti-ZP1_N-terminal, repeat,
trefoil, ZP-N and ZP-C antisera (A) and the anti-ZP3_N-terminal, ZP-N and ZP-C antisera (B) were incubated in the presence (+; odd-numbered lanes, except for lane 11) or
absence (; even-numbered lanes) of the serum–ZP3 mixture and pulled down by magnetic ﬁeld. The immunoprecipitates on the beads were subjected to SDS–PAGE under
reducing conditions, together with the serum and the ZP3 solution (upper and lower panels in lane 11 of A, respectively) followed by immunoblotting with the anti-
ZP1_repeat (anti-ZP1) and anti-ZP3_ZP-C (anti-ZP3) antisera (upper and lower panels, respectively). Migration positions of ZP1 (ﬁlled arrowheads), ZP3 (blank arrowheads),
and immunoglobulin heavy and light chains (single and double asterisks, respectively) are shown on the right. Molecular weights (kDa) are indicated on the left.
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non-glycosylated type I ZP-C domain of chicken ZP3, except that
the ZP-C of ZP3 homologue possesses the type-I speciﬁc ZP-C sub-
domain [16]. (4) Solution structures of the trefoil domain of human
pNR-2/pS2 [59] and the EGF-like domain of human ﬁbrillin-1 [60]
were determined by NMR of the recombinant proteins being
expressed in E. coli. (5) There are neither Cys residue nor
N-glycosylation site in the repeat domain of ZP1 and the
N-terminal peptide of ZP3 in chicken [20,54]. Therefore, we
employed the E. coli strains that facilitate formation of disulﬁde
bonds by carrying the trxB/gor mutations and that enhance the
expression of eukaryotic proteins by containing codons rarely used
in E. coli to produce active proteins efﬁciently, and the inclusion
bodies of the recombinant proteins for the probes were unfolded
and refolded without any reducing agents as described in
Section 4. Immunostaining of the chicken egg coat (Fig. 2) and/or
co-immunoprecipitation of the serum ZP1 and the egg-coat ZP3
(Fig. 4) revealed that all antibodies raised against the recombinant
ZP glycoproteins have high afﬁnities for the natively folded ones.
Although some of the recombinant proteins form covalently linkeddimer or polymers on the beads in the pull-down assay (double
asterisks of Fig. 5), considerable amount of them were remained
as monomer (the lowest double asterisks of Fig. 5).
In our previous study, immunohistochemical analyses of
chicken egg coat conﬁrmed that the ﬁbrous matrix of chicken
egg coat was composed of ZP1 and ZP3, although the distributions
of ZP glycoproteins in the matrix remain unclear partly because of
the absence of clear images [53]. In the present study, we initially
performed immunoﬂuorescence staining of the mature chicken egg
coat with the antisera raised against the domains of chicken
ZP1, ZP3 and ZPD followed by observation under the
confocal laser-scanning microscopy as described in Section 4
(Fig. 2A and B). The optical sections showed that antibodies in
the anti-ZP1_N-terminal, trefoil (panels 1 and 2 of Fig. 2B, respec-
tively), repeat (panels 2 and 4 of Fig. 2A) and anti-ZP3_N-terminal
(panel 5 of Fig. 2B) antisera bound predominantly to the near
surface of the egg-coat ﬁlaments. Considering that the core of the
ﬁlaments showed weak staining with these antisera, and that
the ultrastructural studies of mouse and human egg coat showed
that their large meshed networks are constructed of
A B
Fig. 5. Pull-down assays from the chicken serum containing ZP1 with the recombinant ZP domains of ZP3. Nickel-magnetic beads coated with the control protein (lanes 3 and
5), the recombinant ZP-N (lanes 2, 4 and 6 of A) and ZP-C (lanes 2, 4 and 6 of B) domains of ZP3 (rZP3_ZP-N and ZP-C; A and B, respectively; see Fig. 1) were incubated in the
presence (lanes 2–5) or absence (serum–; lanes 6) of the chicken serum containing ZP1 and pulled down by magnetic ﬁeld followed by subsequent incubation in 4.0% Triton
X-100. The proteins released from the beads by the Triton X-100 treatment (TX-100; lanes 2 and 3), and the ones retained on the beads and released by incubation in the SDS–
PAGE sample buffer containing 2.0% SDS (SDS; lanes 4–6) were subjected to SDS–PAGE under non-reducing conditions, together with the chicken serum (serum; lanes 1),
followed by immunoblotting with the anti-ZP1_repeat antiserum (anti-ZP1). Migration positions of monomeric ZP1 in the serum (arrowheads), the anti-ZP1 positive proteins
in the serum that bound to the recombinant-protein coated beads (single asterisks) and in the recombinant ZP-N and ZP-C solutions (double asterisks), and the control
protein (triple asterisks) are shown on the right. Molecular weights (kDa) are indicated on the left.
A B
Fig. 6. Far-Western blot analyses of the egg-coat proteins with the recombinant domains of ZPD. The proteins in the egg coat (odd-numbered lanes in A) and the crude ZPD
solution prepared as described in Section 4 (even-numbered lanes in A and lanes 1–3 in B) were separated by SDS–PAGE under non-reducing conditions followed by
electroblotting onto nitrocellulose membranes. (A) The blocked membranes were incubated with the control protein (lanes 1 and 2), recombinant EGF-like (EGF; lanes 3 and
4), ZP-N (lanes 5 and 6) and ZP-C (lanes 7 and 8) domains of ZPD (rZPDs) (see Fig. 1) as Trx-tagged probes followed by immunostaining with rabbit anti-Trx antibody. The
proteins in the SDS–PAGE gel were also stained with CBB (lanes 9 and 10). (B) The blocked membranes were preincubated with the mouse anti-tag (lane 1), anti-ZPD_ZP-N
and ZP-C (lanes 2 and 3, respectively) antisera being produced as described in Section 4 prior to the incubation with the recombinant ZP-C domain of ZPD (rZPD_ZP-C), and
immunostained with rabbit anti-Trx antibody. Migration positions of dimeric (di-) and monomeric (mo-) ZP1, ZPD and ZP3 (arrowheads), and one of the previously-reported
anti-ZP1 positive proteins (asterisk) are shown on the right. Molecular weights (kDa) are indicated on the left.
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these data suggest that the ﬁlaments of chicken egg coat might
be the tightly packed bundles of the ZP1–ZP3 ﬁbrils, in which theantibodies are prevented from binding to the core. Surprisingly,
the antibodies in the anti-ZP1_ZP-N and anti-ZP3_ZP-N antisera
(panels 3 and 6 of Fig. 2B, respectively) bound to the surface of
H. Okumura et al. / FEBS Open Bio 5 (2015) 454–465 461the ﬁlaments as punctuate patterns, and the ones in the
anti-ZP1_ZP-C and anti-ZP3_ZP-C antisera (panels 4 and 7 of
Fig. 2B, respectively) did not bind to the ﬁlaments. Considering that
the reactivity of all antisera generated in this study were conﬁrmed
by immunoblotting under non-reducing conditions (Supplement
Fig. S1A) and/or co-immunoprecipitation of native ZP glycopro-
teins (Fig. 4), these results suggest that the ZP1 and ZP3 molecules
are arranged to form ﬁbrils in a manner that their ZP-C domains
are deeply embedded in the core, the ZP-N domains are located
in the medial layer, and that the other regions are exposed on
the surface. In our previous study, the antibodies in the antiserum
against full-length ZP3 appeared to bind more homogeneously to
whole region in the egg-coat ﬁlaments [53], probably because
the relative abundance of the antibodies against the N-terminal
peptide of ZP3 in the antiserum might be insufﬁcient to stain near
surface of the ﬁlaments intensely. On the other hand, the distribu-
tion of ZPD in the egg-coat matrix was visualized in this study. The
optical sections showed that antibodies in the anti-ZPD_EGF, ZP-N
and ZP-C antisera (panels 8–10 of Fig. 2B, respectively) bound to
the thin layer on the interstices of egg-coat ﬁlaments with similar
afﬁnities. Considering that ZPD is easily released from the egg coat
by mechanical treatment as reported previously [24], the results
suggest that ZPD forms homopolymers or aggregates to deposit
on the interstices of ZP1–ZP3 matrix.
Subsequently, the domains of ZP1 involved in the intermolecu-
lar interactions of ZP glycoproteins in the egg-coat matrix were
determined by far-Western blot analyses of the egg-coat proteins
with the recombinant domains of ZP1 as probes (Fig. 3A and B).
The results indicate that the repeat and ZP-C domains of ZP1 bind
to ZP1 and ZP3, respectively, and that both of them probably have
some afﬁnities to ZPD and/or the previously reported anti-ZP1 pos-
itive proteins [47,53] (lanes 3 and 6 of Fig. 3A). Considering that
only the repeat domain has a high binding afﬁnity to ZP1 among
the ﬁve domains of ZP1 (lane 3 of Fig. 3A), the data suggest that
ZP1 could form the non-covalently linked homodimer and/or poly-
mer in the matrix through the repeat domain, and the anti-ZP1
positive proteins [47,53] might possess parts of the repeat domain.
Unexpectedly, neither the preincubation of ZP3 with the
anti-ZP3_ZP-N nor anti-ZP3_ZP-C antiserum inhibited the binding
of the rZP1_ZP-C to ZP3 effectively (Fig. 3B), suggesting that the
ZP-C domain of ZP1 has greater afﬁnities for the ZP-N and/or
ZP-C domains of ZP3 than antibodies in the anti-ZP3_ZP-N
and ZP-C antisera.
In our previous study, it is suggested that the ZP1 in the blood of
chicken, i.e. laying hen, (serum ZP1) interacts with the ZP3 being
expressed in the ovary to form disulﬁde-linked homodimer and ﬁl-
amentous complexes with ZP3, and that the ZP1–ZP3 complexes
probably play an important role as a scaffold of the egg-coat matrix
[47,48]. We further determined the domains of ZP glycoproteins
involved in the assembly of ZP1–ZP3 complexes, which are proba-
bly incorporated into the ZP1–ZP3 matrix during egg-coat forma-
tion [47,48]. Co-immunoprecipitation of the serum ZP1 and the
egg-coat ZP3 with the antisera against domains of ZP1 and ZP3
(Fig. 4A and B, respectively) suggest that the N-terminal, repeat
and ZP-C domains of ZP1, and the N-terminal peptide and the
ZP-N domain of ZP3 are exposed on the surface of the ZP1–ZP3
complexes, while the trefoil and ZP-N domains of ZP1, and the
ZP-C domain of ZP3 are not. ZP1 was immunoprecipitated by anti-
bodies in all the anti-ZP1 antisera from the serum–ZP3 mixture at
similarly high efﬁciencies (upper panels of Fig. 4A), suggesting that
there was an excess of ZP1. On the other hand, pull-down assays
from the chicken serum with the recombinant ZP-N and ZP-C
domains of ZP3 (Fig. 5A and B, respectively) demonstrate that the
serum ZP1 assemble with the egg-coat ZP3 through the interac-
tions with the ZP-C domain of ZP3 to form the 4.0% Triton
X-100-resistant rigid complex. Taken together with the above data,these results suggest that ZP1 is bound to ZP3 through their ZP-C
domains with unusually high afﬁnities either in the egg coat or
the ZP1–ZP3 complexes, and that the ZP-C domain of ZP1 being
exposed on the surface of the ZP1–ZP3 complexes might become
embedded within the ZP1–ZP3 ﬁbrils during the egg-coat forma-
tion. Interestingly, the serum ZP1 did not form intermolecular
disulﬁde bonds by the interaction with the rZP3_ZP-C (lane 4 of
Fig. 5B), whereas our previous studies suggest that the serum
ZP1 interacts with full-length ZP3 to form disulﬁde-linked homod-
imer [47,48], implying that full-length ZP3 possessing both ZP-N
and ZP-C domains are required for the ZP1 dimerization.
Considering that chicken ZP3 is thought to form a non-covalently
linked homodimer through its ZP-N and ZP-C domains belonging
to opposite molecules as observed in the crystal structure [16], it
is expected that the polymerization of the ZP1–ZP3 complexes
through the interaction between ZP3 molecules increases accessi-
bility of ZP1 monomers to form the dimer.
In our previous study, it is suggested that the third major com-
ponent of mature chicken egg coat, ZPD, is loosely attached to the
ZP1–ZP3 matrix and probably self-associates to form aggregates
[24]. In the present study, the domains of ZPD involved in the for-
mation of above-mentioned ZPD homopolymers or aggregates and
the binding to the ZP1–ZP3 matrix were also determined by
far-Western blot analyses of both the egg-coat proteins and par-
tially puriﬁed ZPD with the recombinant domains of ZPD as probes
(Fig. 6A and B). The results indicate that both the ZP-N and ZP-C
domains of ZPD bind to ZP1 with similarly high afﬁnities (lanes 5
and 7 of Fig. 6A), the ZP-C domain of ZPD binds to ZPD itself with
signiﬁcantly higher afﬁnities than the ZP-N domain (lanes 6 and 8
of Fig. 6A), and that the ZP-C domain of ZPD has some afﬁnities to
ZP3 (lane 7 of Fig. 6A). In addition, the binding of the ZP-C domain
of ZPD to ZPD itself was signiﬁcantly inhibited by anti-ZPD_ZP-C
antiserum (Fig. 6B). These results suggest that ZPD forms
homopolymers perhaps in the head-to-head and tail-to-tail
arrangements to be attached to the ZP1–ZP3 matrix.
Interestingly, the ZP-N domain of ZPD bound to one of the
anti-ZP1 positive proteins [47,53] (asterisks) with signiﬁcantly
higher afﬁnities than the other domains of ZPD (lane 5 of
Fig. 6A). Considering that both ZP-N and ZP-C domains of ZPD bind
to ZP1 with high afﬁnities, and that the anti-ZP1 positive proteins
[47,53] are thought to contain the repeat sequences as discussed
above, the ZP-N but not ZP-C domain of ZPD might have a high
afﬁnity to the repeat domain of ZP1.
Interestingly, chicken ZPD (GenBank: BAD13713) and human
uromodulin (NCBI Reference Sequence: NP_001008390) share the
Calcium-binding EGF-like and the ZP domains, although human
uromodulin possess two additional EGF-like domains and the
uncharacterized D8C domain [62]. Furthermore, a database homol-
ogy search using NCBI BLAST [63] showed that C58–I362 of the
chicken ZPD possesses signiﬁcant sequence homology with
C306–I604 of the human uromodulin (29% identities and 48% pos-
itives). These data and the recent reports that the uromodulin or
THP plays important roles in the protection from bacterial infec-
tion and the regulation of immunosystems in urinary tract
[62,64] imply that ZPD may be a close relative of the uromodulin
and that ZPD might have functions in the defense of oocyte or early
embryo in the egg coat.
In conclusion, the results of this study suggest that ZP1 and ZP3
assemble into probably helical ﬁbrils through strong interactions
between their ZP-C domains in a manner that the ZP-C domains
are deeply embedded in the core, the ZP-N domains are located
in the medial layer, and that the N-terminal, repeat, trefoil domains
of ZP1, the N-terminal peptide of ZP3 and probably the glycan
chains on the ZP-N/ZP-C linker regions are exposed on the surface.
The results also suggest that the ZP1–ZP3 ﬁbrils further assemble
into bundles through the intermolecular disulﬁde bonds between
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tions between the repeat domains of ZP1 to form the ZP1–ZP3
matrix. In addition, the results suggest that ZPD forms homopoly-
mers presumably in the head-to-head and tail-to-tail arrange-
ments and attaches to the ZP1–ZP3 ﬁbrils located on the surface
of the matrix to form the ZPD aggregates. A tentative model for
the architecture of chicken egg coat is shown in Fig. 7, although
detailed domain conﬁgurations of the ZP glycoproteins, mecha-
nisms of the ZP1 dimerization and involvements of either
the above-mentioned non-covalent ZP3 dimer [16] or the
previously-reported ZP3 isoforms [53], in the formation of the
ZP1–ZP3 ﬁbrils and the ZPD aggregates remain to be elucidated.
Our model of the egg-coat architecture is compatible with the
mouse model [2,49], and might be applicable to the egg coat of
all other vertebrates by replacing the ZP-glycoprotein components.
The model presented here might provide new insights into
egg-coat formation mechanisms that could have application in
research into developing novel approaches to control fertility by
modifying the egg-coat architecture for human/veterinary medi-
cine including therapies for infertility associated with the
zona-pellucida dysmorphism and/or mutations in ZP glycoproteins
[55–57].
4. Materials and methods
All animal procedures were performed according to the guideli-
nes for the care and use of experimental animals of Meijo
University. The animal protocols were approved by an institutional
animal care and use committee (2013-A-E-1).Fig. 7. A tentative model for the architecture of the chicken egg-coat matrix. A schematic
from the present and previous studies. Chicken ZP1 containing the N-terminal (N-term), r
and the ZP-N/ZP-C linker region assembles with chicken ZP3 containing the N-terminal p
the interactions between their ZP-C domains to form the helical ZP1–ZP3 ﬁbrils. The N-
mentioned glycans are exposed on the surface of the ZP1–ZP3 ﬁbrils to overlie the ZP-N
disulﬁde bonds between the N-terminal domains of ZP1 (a), and non-covalent interactio
addition, chicken ZPD containing the calcium-binding EGF-like (EGF-like), ZP-N and ZP-C
forms homopolymers in the head-to-head and tail-to-tail arrangements and attaches to th
aggregates. Schematic diagrams of ZP1, ZP3 and ZPD are drawn based on the domain
accession code: 3NK3) [16]. All the putative N-glycosylation sites of the ZP glycoprotein4.1. Preparation of ZP3 and ZPD from chicken egg coat, and chicken
serum
Chicken egg coat was isolated from the pre-ovulatory mature
follicles, and the ZP3 and crude ZPD solutions were prepared as
previously described [24], except that the gel-ﬁltration chromatog-
raphy was performed using ÄKTA prime plus (GE Healthcare,
Uppsala, Sweden) equipped with HiPrep™ 16/60 Sephacryl™
S-200 HR column (GE Healthcare), and the pooled fraction contain-
ing ZP3 was dialyzed against PBS to be used as the ZP3 solution.
The chicken serum containing ZP1 was prepared as previously
described [47].
4.2. Protein determination
Protein concentrations were estimated by BCA protein assay kit
(Pierce, Rockford, IL) using BSA as the standard, except that the
concentration of ZP1 in the chicken serum were determined by
densitometric analyses of the immunoblots for the chicken serum
with the anti-ZP1_repeat antisera using the below-mentioned con-
trol protein as the standard. Amount of the His6-tagged proteins
bound to the nickel beads were estimated by densitometric analy-
ses of the CBB-stained gel bands using BSA as the standard.
4.3. Production of recombinant domains of chicken ZP glycoproteins
Complementary DNAs (cDNAs) encoding structural and/or
functional domains of ZP glycoproteins (Fig. 1) were ampliﬁed by
PCR using full-length cDNAs of chicken ZP1 [20], ZP3 (GenBank:diagram of the chicken egg-coat matrix architecture was drawn based on the results
epeat, trefoil, ZP-N and ZP-C domains, and N-glycans on both the N-terminal domain
eptide, ZP-N and ZP-C domains, and N- and O-glycans on the linker region through
terminal, repeat, trefoil domains of ZP1, the N-terminal peptide of ZP3 and above-
domains. The ZP1–ZP3 ﬁbrils assemble into bundles through both intermolecular
ns between the repeat domains of ZP1 (b), to form the ﬁbrous ZP1–ZP3 matrix. In
domains, and N-glycans on both the ZP-N domain and the ZP-N/ZP-C linker region
e ZP1–ZP3 ﬁbrils located on the surface of the interstices of ZP1–ZP3 matrix to form
structure of chicken ZP1 and the crystal structure of full-length chicken ZP3 (PDB
s are occupied in this scheme.
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with primer set listed in the Supplement Table S1. The ZP1 cDNA
that we used in this study contains an insertion encoding the addi-
tional 24-aa-long repeat unit in the repeat domain as compared to
the sequence available in GenBank (GenBank: AJ289697) [20]. The
primers in the Supplement Table S1 were designed to amplify
cDNAs encoding the N-terminal, repeat, trefoil, ZP-N and ZP-C
domains of ZP1 (corresponding to nucleotides +73–582, +583–
1707, +1708–1866, +1867–2166 and +2248–2688 of the
GenBank: AJ289697, respectively) [20], the N-terminal peptide,
ZP-N and ZP-C domains of ZP3 (corresponding to nucleotides
+61–165, +166–471 and +538–1041 of the GenBank: D89097,
respectively) [54], and the N-terminal region containing
Calcium-binding EGF-like (EGF-like), ZP-N and ZP-C domains of
ZPD (corresponding to nucleotides +64–255, +256–567 and
+631–1026 of the GenBank: AB114441, respectively) [24] with
NcoI or BamHI site at the 50 end, stop codon at the 30 end, and
XhoI or BamHI site immediately after the stop codon. In addition,
cDNAs encoding the N-terminal and C-terminal halves of ZP
domain (ZP-N + IHP; ZP-N domain followed by the linker region
and IHP, and ZP-C  IHP; ZP-C domain lacking the IHP, respec-
tively) in ZP1 (corresponding to nucleotides +1867–2265 and
+2266–2688 of GenBank: AJ289697, respectively), ZP3 (corre-
sponding to nucleotides +166–564 and +565–1041 of GenBank:
D89097, respectively) and ZPD (corresponding to nucleotides
+256–657 and +658–1026 of GenBank: AB114441, respectively)
were ampliﬁed similarly. The resultant DNA were digested with
the restriction enzymes, and inserted between the same restriction
sites into pET-32a(+) vector (Novagen; Merck Millipore,
Darmstadt, Germany). The fusion proteins carrying thioredoxin
(Trx), hexahistidine (His6) and S tags in this order on the N termi-
nus were expressed in E. coli Rosetta-gami B(DE3) (Novagen) (for
trefoil domain of ZP1, ZP-N and ZP-C domains of ZP3, and
EGF-like domain of ZPD) or Rosetta 2(DE3) (Novagen) (for other
fusion proteins) according to the manufacturer’s instructions. The
cell pellet were resuspended in the sonication buffer (PBS contain-
ing 0.50 M NaCl and 0.20% Triton X-100) and sonicated as
described above followed by centrifugation at 12,000g for 10 min
at 4 C. Soluble fusion proteins in the supernatant (repeat and tre-
foil domains of ZP1, N-terminal peptide of ZP3, and EGF-like
domain of ZPD) were puriﬁed by nickel-afﬁnity chromatography,
according to the manufacturer’s instructions, dialyzed against
PBS and stored at 20 C before use. The precipitates were washed
three times with the inclusion-body (IB) wash buffer (20 mM
Tris–HCl, pH7.5, containing 10 mM EDTA and 1.0% Triton X-100) to
isolate IBs containing insoluble fusion proteins (N-terminal domain
of ZP1, ZP-N and ZP-C domains, the ZP-N + IHP and the ZP-C IHP
of all three ZP glycoproteins). The control protein (vector-encoded
protein) was expressed in E. coli BL21(DE3) (Novagen) being trans-
formed with the empty pET-32a(+) vector (Novagen) as a soluble
protein, and puriﬁed similarly as described above.
4.4. Protein refolding
The recombinant proteins were subjected to the unfold-
ing/refolding reactions. The IBs of insoluble fusion proteins were
suspended at a concentration of 20 mg wet weight/ml in the IB sol-
ubilization buffer (50 mM CAPS, pH 11.0, containing 0.30%
N-lauroylsarcosine) without any additive (for the ZP-N + IHP of
both ZP1 and ZPD: group A), and the buffer supplemented with
4.5 M urea (for N-terminal domain of ZP1, ZP-N and ZP-C domains
of all three ZP glycoproteins, and the ZP-N + IHP of ZP3: group B),
2.0 mM DTT (for the ZP-C  IHPs of both ZP1 and ZPD: group C)
or 0.5 mM DTT (for the ZP-C  IHP of ZP3: group D). After incuba-
tion at room temperature (RT) for 15 min, the IB solutions contain-
ing solubilized fusion proteins were collected by centrifugation ofthe IB suspension at 10,000g for 10 min at 4 C and subjected to
multi-step dialysis method for refolding. The IB solutions were dia-
lyzed against 250 times the volumes of the sample of the dialysis
buffer (20 mM Tris–HCl, pH 8.5) (for the group A) and that supple-
mented with 2.0 M urea (for the group B), 0.20 mM DTT (for the
group C) or 0.050 mMDTT (for the group D) for 16 h at 4 C and sub-
sequently against same volumes of the buffer (for the group A) and
that supplemented with 1.0 M urea (for the group B), 0.10 mM DTT
(for the group C) or 0.025 mM DTT (for the group D) for 3 h at 4 C.
The dialysis was continued through two additional changes with the
same volumes of the dialysis buffer in the absence of urea and DTT
for 3 and 16 h at 4 C, respectively. The refolded protein solutions
were centrifuged at 15,500g for 5 min at 4 C to remove insoluble
materials and stored at 20 C before use.
4.5. Production of antisera against the domains of chicken ZP
glycoproteins
Polyclonal antisera were raised in mice against the
above-mentioned recombinant ZP glycoproteins. Mice were immu-
nized and the antisera were collected as previously described [47].
Trx and His6 tags (but not S tag) were removed using Thrombin
Cleavage Capture Kit (Novagen) from the recombinant trefoil
domain of ZP1, N-terminal peptide of ZP3, and EGF-like and ZP-N
domains of ZPD prior to the immunization. The antisera against
the N-terminal, repeat and trefoil domains of ZP1
(anti-ZP1_N-terminal, repeat, and trefoil, respectively), the
N-terminal peptide of ZP3 (anti-ZP3_N-terminal), the EGF-like
domain of ZPD (anti-ZPD_EGF), the N-terminal half of ZP domain
in ZP1 and ZP3 (anti-ZP1_ZP-N and anti-ZP3_ZP-N, respectively),
the ZP-N of ZPD (anti-ZPD_ZP-N), C-terminal halves of ZP domain
in ZP1, ZP3 and ZPD (anti-ZP1_ZP-C, anti-ZP3_ZP-C and
anti-ZPD_ZP-C, respectively) and the control protein (anti-tag)were
produced. Reactivity of the antiserawas conﬁrmed by immunoblot-
ting of ZP glycoproteins being separated by SDS–PAGE under reduc-
ing and non-reducing conditions (Supplement Fig. S1).
4.6. Immunoﬂuorescent staining and confocal laser-scanning
microscopy of chicken egg coat
Small pieces of isolated egg coat were mounted onto
aminosilane-coated glass slides, incubated with PBS containing
0.10% Triton X-100 at RT for 30 min and washed with cold PBS fol-
lowed by incubation with 2.0% BSA in PBS (2.0% BSA/PBS) at 4 C
overnight for blocking. The BSA-blocked egg coat were incubated
with 2.0% BSA/PBS containing the anti-tag (1:1000), the
anti-ZP1_N-terminal (1:200), repeat (1:2400), trefoil (1:800), ZP-N
(1:20) or ZP-C (1:100), the anti-ZP3_N-terminal (1:10), ZP-N
(1:100) or ZP-C (1:200), or the anti-ZPD_EGF (1:100), ZP-N (1:600)
or ZP-C (1:400) and washed with PBS followed by ﬁnal incubation
with 2% BSA/PBS containing Alexa Fluor 488 goat anti-mouse IgG
(6.7 lg/ml; Molecular Probes, Eugene, OR) at RT for 30 min in dark-
ness. After washing with PBS and the wash buffer (NET; 150 mM
NaCl, 5 mM EDTA, 50 mM Tris–HCl, pH 8.0, 0.05% Triton X-100),
the egg coat was observed under the confocal laser-scanningmicro-
scopy. Imaging was performed on a Zeiss Axio Obserber.Z micro-
scope equipped with LSM 700 laser scanning confocal optics (Carl
Zeiss, Thornwood, NY). A 488-nmdiode laser excitation in combina-
tion with a 490–635 nm band-pass emission ﬁlter was used for
imaging the ﬂuorescent probes. Differential-interference-contrast
(DIC) microscopy images were taken on the same system.
4.7. Co-immunoprecipitation assay
Protein G magnetic beads (25 ll of 50% slurry; New England
Biolabs, Beverly, MA) were prepared according to the
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4 C with gentle agitation in 300 ll of binding buffer (0.1 M sodium
phosphate, pH 8.0) with each of the above-mentioned antisera to
couple antibodies to the beads, pulled by magnetic ﬁeld, and
washed three times with 500 ll of the binding buffer. On the other
hand, the chicken serum containing 5.8 lg of ZP1 was mixed with
the ZP3 solution containing 6.4 lg of ZP3 according to the previ-
ously deﬁned ZP1/ZP3 ratio [47], incubated at 37 C for 16 h to
form the ZP1–ZP3 complexes, diluted up to 300 ll with the binding
buffer, and incubated with the beads, without the antibody cou-
pling for 24 h at 4 C with gentle agitation. The beads were pulled
by magnetic ﬁeld to remove nonspeciﬁcally bound proteins, and
the supernatants or 300 ll of the binding buffer were incubated
with the above-mentioned antibody-bound beads similarly. The
beads were pulled and washed similarly, and half of the immuno-
precipitates on the beads were subjected to SDS–PAGE.
4.8. Pull-down assay
PureProteome™ Nickel Magnetic Beads (30 ll of the 75–80 wt%
suspension; Merck Millipore, Billerica, MA) were equilibrated in
the pull-down binding buffer (50 mM phosphate buffer, pH 8.0,
containing 300 mM NaCl) according to the manufacturer’s instruc-
tions. The equilibrated beads were resuspended in 1.0 ml of PBS
containing 6.0 nM of the His6-tagged proteins or 1.0 ml of 20 mM
Tris–HCl, pH 8.5, followed by incubation with gentle agitation for
16 h at 4 C, pulled by magnetic ﬁeld and washed 3 times with
150 ll of the pull-down binding buffer. The beads carrying 50 pmol
of the fusion proteins or the above-mentioned control protein were
incubated in 300 ll of PBS with or without 50% chicken serum,
pulled similarly and washed with the pull-down binding buffer
as described above. The beads were ﬁnally incubated in 10 ll of
PBS containing 4.0% Triton X-100 (TX-100) for 60 min at RT and
pulled similarly, and 2.0 ll of the TX-100 eluate and one ﬁfth of
the beads carrying proteins being retained after the TX-100 treat-
ment were subjected to SDS–PAGE.
4.9. Gel electrophoresis, immunoblotting, and far-Western (ligand)
blotting
SDS–PAGE was performed according to the method of Laemmli
[65]. The protein samples obtained by the co-immunoprecipitation
and pull-down assays, 5.0 ll of the crude ZPD solution, the ZP3
solution containing 1.0 lg of ZP3, 0.5–1.0 ll of the chicken serum
and 15 lg wet weight of the egg coat were incubated at 100 C
for 5 min in SDS–PAGE sample buffer (62.5 mM Tris–HCl, pH6.8,
containing 2.0% SDS, 0.0020% bromophenol blue, 10% glycerol) in
the presence or absence of 42 mM DTT (reducing or
non-reducing conditions, respectively) and loaded onto the poly-
acrylamide gel following removal of the insoluble materials or
the beads by centrifugation or magnetic ﬁeld, respectively.
Proteins in the gel were electroblotted onto a nitrocellulose mem-
brane for immunoblotting and far-Western (ligand) blotting.
Coomassie Brilliant Blue (CBB) staining, immunoblotting and
far-Western blotting were performed as previously described
[47], except that, for far-Western blotting, the gelatin-blocked
membranes were preincubated in the incubation buffer (NETG;
150 mM NaCl, 5 mM EDTA, 50 mM Tris–HCl, pH8.0, 0.05% Triton
X-100, 0.25% gelatin) containing 10.6–82.1 nM of the
above-mentioned recombinant proteins as probes at 4 C for 16 h
prior to incubation with primary antibodies. Furthermore, to
examine whether the binding afﬁnities of the probes to the protein
bands on the membrane were affected by the antisera against the
ZP-N and ZP-C domains, the blocked membranes were preincu-
bated with the anti-ZP3_ZP-N (1:50) anti-ZP3_ZP-C (1:1000),
anti-ZPD_ZP-N (1:3000) or anti-ZPD_ZP-C (1:2000) at RT for60 min prior to incubation with the probes. The
above-mentioned mouse anti-ZP1_repeat (1:2000), mouse
anti-ZP3_ZP-C (1:2000) or rabbit anti-Trx (Anti-Thioredoxin anti-
body produced in rabbit; Sigma–Aldrich, St. Louis, MO)
(1:10,000) were used for primary antibodies, and POD-linked
anti-mouse or anti-rabbit IgG (Amersham ECL™ Anti-mouse and
Anti-rabbit IgG Peroxidase-linked species speciﬁc whole antibody
(from sheep or donkey, respectively); GE Healthcare) (1:10,000)
were used for secondary antibody, unless otherwise noted.Author contributions
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